20-13559007-C-A
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_017714.3(TASP1):c.675+1G>T variant causes a splice donor, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_017714.3 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TASP1 | ENST00000337743.9 | c.675+1G>T | splice_donor_variant, intron_variant | Intron 8 of 13 | 1 | NM_017714.3 | ENSP00000338624.4 | |||
TASP1 | ENST00000455532.5 | c.606+1G>T | splice_donor_variant, intron_variant | Intron 7 of 9 | 5 | ENSP00000400580.1 | ||||
TASP1 | ENST00000465381.5 | n.572+21890G>T | intron_variant | Intron 6 of 9 | 5 | |||||
TASP1 | ENST00000480436.5 | n.759+1G>T | splice_donor_variant, intron_variant | Intron 8 of 13 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1416254Hom.: 0 Cov.: 26 AF XY: 0.00 AC XY: 0AN XY: 704766
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Suleiman-El-Hattab syndrome Pathogenic:1
Variant summary: TASP1 c.675+1G>T is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Several computational tools predict a significant impact on normal splicing: three predict the variant abolishes a 5' splicing donor site. However, these predictions have yet to be confirmed by functional studies. The variant was absent in 232484 control chromosomes (gnomAD). To our knowledge, no occurrence of c.675+1G>T in individuals affected with Suleiman-El-Hattab syndrome and no experimental evidence demonstrating its impact on protein function have been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.